Clopidogrel and membranous nephropathy

Lancet

Volumn 354, Issue 9188, 1999, Pages 1443-1444

  Tholl, U ^a   Anlauf, M ^a   Helmchen, U ^b  

^a Medical Clinic II   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; TICLOPIDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG SENSITIZATION; HEART INFARCTION; HUMAN; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL;

EID: 0033598572     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)02586-6     Document Type: Article

References (5)

1. Sharis P.J., Cannon C.P., Loscalzo J. The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med. 129:1998;394-405.
2. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 348:1996;1329-1339.
3. Elsman P., Zijlstra F. Ticlopidine and renal function. Lancet. 348:1996;273-274.
4. Virdee M., Collinson J., Stables R.H. Ticlopidine and renal function. Lancet. 348:1996;1031-1032.
5. Rosen H., El-Hennawy A.S., Greenberg S., Chen C.K., Nicastri A.D. Acute interstitial nephritis associated with ticlopidine. Am J Kidney Dis. 25:1995;934-936.